查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594685

光学临床前影像市场：按产品类型、最终用途划分 - 2025-2030 年全球预测

Optical Preclinical Imaging Market by Product Type (Consumables, Device, Software), End-Use (Pharma & Biotech Companies, Research Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

光学临床前影像市场2023年估值为13.2亿美元，预计到2024年将达到15.1亿美元，复合年增长率为14.39%，预计到2030年将达到33.9亿美元。

光学临床前影像市场包括用于实验室研究阶段的非侵入性视觉化，以监测活体动物（主要是囓齿动物）的疾病进展、药物疗效和生物过程。这个利基市场对于转化研究是必要的，动物模型的见解有助于理解和治疗人类疾病，并且对于药物开发和生物医学至关重要。应用范围广泛，包括肿瘤学、神经病学、心臟病学和干细胞研究，其使用在学术机构、製药和生物技术领域的临床前环境中至关重要。主要成长动力包括萤光和生物发光等成像技术的技术进步，这些技术提高了解析度和灵敏度。慢性病发病率的上升、研发成本的上升以及人类和动物测试的更道德替代方案的推广是市场扩张的进一步驱动力。新的机会包括整合人工智慧以增强影像分析、小型化以及开发多模态成像系统以提供跨生物系统的全面见解。然而，该市场面临设备成本高、监管环境复杂以及对技术人员的需求等限制，为新进入者设置了障碍。遵守不断发展的道德标准并检验准确模拟人类疾病的动物模型仍然是一个挑战。未来的创新可以集中在减少成像技术的侵入性和成本并扩大其可用性。鼓励企业投资与学术研究机构的合作伙伴关係，以利用尖端技术并在研究基础设施不断发展的新兴地区寻求市场。光学临床前成像市场的本质是动态的，受到快速技术创新以及与各个生命科学领域的紧密联繫的推动。

主要市场统计
基准年[2023] 13.2亿美元
预测年份 [2024] 15.1亿美元
预测年份 [2030] 33.9亿美元
复合年增长率（%） 14.39%

市场动态：揭示快速发展的光学临床前成像市场的关键市场洞察

供需的动态交互作用正在改变光学临床前成像市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 临床前影像在各领域的使用增加
    • 临床研究组织 (CRO) 和製药公司的增加
    • 增加在生命科学和化妆品领域的应用
  • 市场限制因素
    • 安装和营运成本高
  • 市场机会
    • 分子成像技术的进展
    • 增加官民合作关係资金筹措以支持临床前研究
  • 市场问题
    • 严格的法律规范

波特五力：驾驭光学临床前影像市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解光学临床前影像市场的外部影响

外部宏观环境因素在塑造光学临床前成像市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解光学临床前影像市场的竞争格局

对光学临床前成像市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵：光学临床前影像市场供应商的绩效评估

FPNV定位矩阵是评估光学临床前影像市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划光学临床前影像市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，光学临床前成像市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 临床前影像在各领域的使用增加
      • 临床研究组织 (CRO) 和製药公司的增加
      • 增加在生命科学和化妆品领域的应用
    • 抑制因素
      • 安装和营运成本高
    • 机会
      • 分子影像技术进步
      • 增加官民合作关係的资金以支持临床前研究
    • 任务
      • 严格的法规结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章光学临床前影像市场：依产品类型

  • 介绍
  • 消耗品
  • 装置
    • 生物发光
      • 腔肠素
      • 萤光素
      • 萤光素原
    • 萤光
      • 绿色萤光蛋白
      • 红外线染料
      • 红色萤光蛋白
  • 软体

第七章光学临床前影像市场：依最终用途分类

  • 介绍
  • 製药和生物技术公司
  • 研究所

第八章美洲光学临床前影像市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太光学临床前影像市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲光学临床前影像市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies Inc.
  • Analytik Jena GmbH
  • Angstrom Advanced Inc
  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co.KG
  • Bruker Corporation
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • INDEC Systems, Inc.
  • LI-COR, Inc.
  • Magnetic Insight, Inc.
  • MBF Bioscience
  • Mediso Ltd.
  • Milabs BV
  • Miltenyi BIoTec BV & Co. KG
Product Code: MRR-7C5681F867B6

The Optical Preclinical Imaging Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 14.39%, to USD 3.39 billion by 2030.

The optical preclinical imaging market is focused on non-invasive visualization techniques used in laboratory research stages to monitor disease progression, drug efficacy, and biological processes in live animals, primarily rodents. This niche market is necessary for translational research, where insights from animal models contribute to the understanding and treatment of human diseases, making it indispensable in drug development and biomedicine. Applications extend across oncology, neurology, cardiology, and stem cell research, with its usage vital in academia, pharmaceutical, and biotechnology sectors for preclinical scopes. Key growth drivers include technological advancements in imaging techniques, such as fluorescence and bioluminescence, which enhance resolution and sensitivity. The increasing prevalence of chronic diseases, escalating R&D expenditures, and the push for more ethical alternatives to human and animal testing further fuel market expansion. Emerging opportunities lie in integrating artificial intelligence for enhanced image analysis, miniaturization, and the development of multimodal imaging systems that provide comprehensive insights across biological systems. However, the market faces limitations in high equipment costs, complex regulatory landscapes, and the demand for skilled personnel, which can act as barriers for new entrants. Compliance with evolving ethical standards and the validation of animal models to accurately mimic human diseases remain challenging. Future innovation could focus on reducing the invasiveness and cost of imaging technologies, broadening their accessibility. Companies are recommended to invest in partnerships with academic and research institutions to leverage cutting-edge advancements and to pursue markets in emerging regions where research infrastructure is growing. The nature of the optical preclinical imaging market is dynamic, driven by rapid technological innovation and a strong intersection with various life sciences disciplines, offering vast potential for growth but demanding agility and forward-thinking strategies from stakeholders.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 3.39 billion
CAGR (%) 14.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased use of preclinical imaging in different sectors
    • Growing number of clinical research organizations (CROs) and pharmaceutical companies
    • Increasing applications in life science and cosmetic
  • Market Restraints
    • High installation and operational costs
  • Market Opportunities
    • Technological advancement in molecular imaging
    • Rising funding from public-private partnership to support pre clinical researches
  • Market Challenges
    • Strict regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Optical Preclinical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optical Preclinical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optical Preclinical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optical Preclinical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optical Preclinical Imaging Market

A detailed market share analysis in the Optical Preclinical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optical Preclinical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optical Preclinical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optical Preclinical Imaging Market

A strategic analysis of the Optical Preclinical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Analytik Jena GmbH, Angstrom Advanced Inc, Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG, Bruker Corporation, FUJIFILM Holdings Corporation, General Electric Company, INDEC Systems, Inc., LI-COR, Inc., Magnetic Insight, Inc., MBF Bioscience, Mediso Ltd., Milabs B.V., and Miltenyi Biotec B.V. & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Optical Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Consumables, Device, and Software. The Device is further studied across Bioluminescence and Fluorescence. The Bioluminescence is further studied across Coelenterazine, Luciferins, and Proluciferins. The Fluorescence is further studied across Green Fluorescent Proteins, Infrared Dyes, and Red Fluorescent Proteins.
  • Based on End-Use, market is studied across Pharma & Biotech Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased use of preclinical imaging in different sectors
      • 5.1.1.2. Growing number of clinical research organizations (CROs) and pharmaceutical companies
      • 5.1.1.3. Increasing applications in life science and cosmetic
    • 5.1.2. Restraints
      • 5.1.2.1. High installation and operational costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in molecular imaging
      • 5.1.3.2. Rising funding from public-private partnership to support pre clinical researches
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Optical Preclinical Imaging Market, by Product Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Device
    • 6.3.1. Bioluminescence
      • 6.3.1.1. Coelenterazine
      • 6.3.1.2. Luciferins
      • 6.3.1.3. Proluciferins
    • 6.3.2. Fluorescence
      • 6.3.2.1. Green Fluorescent Proteins
      • 6.3.2.2. Infrared Dyes
      • 6.3.2.3. Red Fluorescent Proteins
  • 6.4. Software

7. Optical Preclinical Imaging Market, by End-Use

  • 7.1. Introduction
  • 7.2. Pharma & Biotech Companies
  • 7.3. Research Institutes

8. Americas Optical Preclinical Imaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Optical Preclinical Imaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Optical Preclinical Imaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies Inc.
  • 2. Analytik Jena GmbH
  • 3. Angstrom Advanced Inc
  • 4. Aspect Imaging Ltd.
  • 5. Berthold Technologies GmbH & Co.KG
  • 6. Bruker Corporation
  • 7. FUJIFILM Holdings Corporation
  • 8. General Electric Company
  • 9. INDEC Systems, Inc.
  • 10. LI-COR, Inc.
  • 11. Magnetic Insight, Inc.
  • 12. MBF Bioscience
  • 13. Mediso Ltd.
  • 14. Milabs B.V.
  • 15. Miltenyi Biotec B.V. & Co. KG

LIST OF FIGURES

  • FIGURE 1. OPTICAL PRECLINICAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPTICAL PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPTICAL PRECLINICAL IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COELENTERAZINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY LUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PROLUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY GREEN FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY INFRARED DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RED FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023